Risk factors for the development of retroperitoneal hematoma after percutaneous coronary intervention in the era of glycoprotein IIb/IIIa inhibitors and vascular closure devices
- 1 February 2005
- journal article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 45 (3), 363-368
- https://doi.org/10.1016/j.jacc.2004.10.042
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Arterial puncture closing devices compared with standard manual compression after cardiac catheterization: systematic review and meta-analysisACC Current Journal Review, 2004
- Endogenous Estrogen Deficiency Reduces Proliferation and Enhances Apoptosis-Related Death in Vascular Smooth Muscle CellsCirculation, 2004
- A Clinical Trial of Abciximab in Elective Percutaneous Coronary Intervention after Pretreatment with ClopidogrelThe New England Journal of Medicine, 2004
- The Clinical Spectrum of Retroperitoneal Hematoma in Anticoagulated PatientsMedicine, 2003
- Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary InterventionJAMA, 2003
- Common femoral artery anatomy is influenced by demographics and comorbidity: Implications for cardiac and peripheral invasive studiesCatheterization and Cardiovascular Interventions, 2001
- Modifiable Risk Factors for Vascular Access Site Complications in the IMPACT II Trial of Angioplasty With Versus Without EptifibatideJournal of the American College of Cardiology, 1998
- Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in womenJournal of the American College of Cardiology, 1994
- Vascular complications after balloon and new device angioplasty.Circulation, 1993
- Role of femoral vessel catheterization and altered hemostasis in the development of extraperitoneal hematomas: CT study in 44 patients.American Journal of Roentgenology, 1993